Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.10B.
ENTERPRISE VALUE (EV)
$1.10B
Avalyn Pharma Inc. Common Stock
Market Cap
$1.15B
Enterprise Value (EV)
$1.10B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.15B | $1.10B |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | $1.40B |
| Nektar Therapeutics (NKTR)vs › | $1.17B | $1.27B |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | $628.99M |
| OPKO Health, Inc. (OPK)vs › | $1.14B | $1.23B |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | $1.60B |
| Harrow Health, Inc. (HROW)vs › | $1.13B | $1.35B |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.11B | $1.01B |
| Innovage Holding Corp. (INNV)vs › | $1.21B | $1.20B |
| MannKind Corporation (MNKD)vs › | $1.22B | $1.50B |
Market Cap
$1.15B
Total Debt
$0.00
Cash
$52.31M
Enterprise Value
$1.10B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
